BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36264567)

  • 1. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
    Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors.
    Massa ST; Osazuwa-Peters N; Adjei Boakye E; Walker RJ; Ward GM
    JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):239-249. PubMed ID: 30789634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
    Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a Brief Tele-Cognitive Behavioral Treatment vs Attention Control for Head and Neck Cancer Survivors With Body Image Distress: A Pilot Randomized Clinical Trial.
    Graboyes EM; Maurer S; Balliet W; Li H; Williams AM; Osazuwa-Peters N; Yan F; Padgett L; Rush A; Ruggiero KJ; Sterba KR
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):54-62. PubMed ID: 36454561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke Risk in Survivors of Head and Neck Cancer.
    Yip PL; Zheng H; Cheo T; Tan TH; Lee SF; Leong YH; Wong LC; Tey J; Ho F; Soon YY
    JAMA Netw Open; 2024 Feb; 7(2):e2354947. PubMed ID: 38349657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
    Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
    J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to the American Cancer Society Head and Neck Cancer Survivorship Care Guideline According to Chart Review: A Nested Retrospective Cohort Pilot Study.
    Salley JR; Day AT; Balachandra S; Mehr J; Sumer BD; Sher DJ; Mayfield Arnold E; Danphuong Ho E; Lee SC; Eary R
    Ann Otol Rhinol Laryngol; 2023 May; 132(5):481-491. PubMed ID: 35723192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
    Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket costs and burden among rural breast cancer survivors.
    Pisu M; Azuero A; Benz R; McNees P; Meneses K
    Cancer Med; 2017 Mar; 6(3):572-581. PubMed ID: 28229562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Risk of Body Image-Related Distress in Patients With Head and Neck Cancer.
    Macias D; Hand BN; Maurer S; Balliet W; Ellis MA; Pipkorn P; Huang AT; Nilsen ML; Ruggiero KJ; Williams AM; Marsh CH; Li H; Rhoten BA; Sterba KR; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1019-1026. PubMed ID: 34236423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Baddour K; Fadel M; Zhao M; Corcoran M; Owoc MS; Thomas TH; Sabik LM; Nilsen ML; Ferris RL; Mady LJ
    Head Neck; 2021 Oct; 43(10):3062-3075. PubMed ID: 34235804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Suicidal Self-directed Violence Among US Veteran Survivors of Head and Neck Cancer.
    Nugent SM; Morasco BJ; Handley R; Clayburgh D; Hooker ER; Ganzini L; Knight SJ; Chen JI; Sullivan DR; Slatore CG
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):981-989. PubMed ID: 34617963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
    Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
    Narang AK; Nicholas LH
    JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding financial toxicity in head and neck cancer survivors.
    Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
    Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.
    Kawakita D; Abdelaziz S; Chen Y; Rowe K; Snyder J; Fraser A; Smith K; Herget K; Deshmukh V; Newman M; Monroe M; Hashibe M
    Cancer; 2020 Feb; 126(4):879-885. PubMed ID: 31721181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer.
    Nocon CC; Kennedy A; Jaffe J; Pruitt J; Kuchta K; Bhayani MK
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):632-637. PubMed ID: 33983375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads.
    Sterba KR; Armeson K; Zapka J; Scallion MA; Garris TK; Graboyes EM; Ruggiero K; Day TA
    J Cancer Surviv; 2019 Feb; 13(1):117-129. PubMed ID: 30645719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.